معرفی
Jeffrey A Linder serves as the Michael A. Gertz Professor of Medicine and Chief of the Division of General Internal Medicine at Northwestern University Feinberg School of Medicine. His institutional affiliations include the Institute for Public Health and Medicine (IPHAM) - Center for Primary Care Innovation and the Northwestern University Clinical and Translational Sciences Institute (NUCATS).
His educational background comprises:
- MD from Northwestern University Feinberg School of Medicine (1997)
- MPH from Harvard School of Public Health (2002)
- Internal Medicine Internship and Residency at University of California-San Francisco Medical Center (1998-2000)
- General Medicine Fellowship at Massachusetts General Hospital (2002)
Dr. Linder's research centers on improving U.S. primary care through electronic health records optimization, behavioral science applications for clinician behavior change, antibiotic stewardship, and geriatric care innovation. His work bridges health services research, quality improvement, and medical decision science to address systemic healthcare challenges.
His 2025 publications reveal critical trends: reducing medical overuse via behavioral nudges, analyzing non-visit antibiotic prescribing patterns, identifying disparities in Medicare wellness visits, and examining pandemic impacts on chronic disease management in aging populations. These studies collectively advance evidence-based primary care delivery.
His scientific recognition includes:
- Charles C. Shepard Science Award (2017) from CDC for groundbreaking antibiotic prescription research
Dr. Linder leads the PREVENTABLE clinical trial investigating statin therapy for dementia prevention in older adults while maintaining active clinical practice in primary care and inpatient medicine. His industry collaborations with pharmaceutical companies support translational research initiatives.
As Division Chief, he directs Northwestern's General Internal Medicine team focused on primary care innovation, clinical education, and health equity research following the recent separation from Geriatrics into distinct divisions.
